Genetic evidence of PICALM as a risk factor for AD was further confirmed by revealing that the adaptor complex AP2 and PICALM interact with LC3 to mediate the degradation of Alzheimer's C-terminal fragment APP via autophagy [173]. Here, APP is linked to Alzheimer disease.